首页|格列齐特联合二甲双胍治疗2型糖尿病患者的疗效分析

格列齐特联合二甲双胍治疗2型糖尿病患者的疗效分析

Efficacy of Gliclazide Combined with Metformin in the Treatment of Pa-tients with Type 2 Diabetes

扫码查看
目的 探讨格列齐特联合二甲双胍治疗2型糖尿病患者的临床疗效.方法 选取2022年3月—2023年3月普宁华侨医院收治的60例2型糖尿病患者作为研究对象,依据治疗模式的不同分为两组,各30例,观察组选用格列齐特联合二甲双胍,对照组选用格列齐特,比较两组临床疗效.结果 治疗后,观察组总有效率高于对照组,各项血糖、血脂指标均优于对照组,不良反应发生率低于对照组,差异有统计学意义(P均<0.05).结论 格列齐特联合二甲双胍对2型糖尿病有较好的疗效,不仅能有效地控制血糖和血脂,还能减少单独应用格列齐特产生的不良反应.
Objective To investigate the clinical efficacy of gliclazide combined with metformin in the treatment of type 2 diabetes.Methods 60 patients with type 2 diabetes treated in Puning Overseas Chinese Hospital from March 2022 to March 2023 were selected as the study objects,and were divided into two groups with 30 cases in each group according to different treatment modes.Gliclazide combined with metformin was used in the observation group,and Gliclazide was used in the control group.The clinical efficacy of the two groups was compared.Results After treat-ment,the total effective rate of the observation group was higher than that of the control group,the indexes of blood sugar and blood lipid were better than those of the control group,and the incidence of adverse reactions was lower than that of the control group,the differences were statistically significant(all P<0.05).Conclusion Gliclazide com-bined with metformin has a good effect on type 2 diabetes mellitus,not only can effectively control blood glucose and lipids,but also reduce the adverse reactions caused by gliclazide alone.

GliclazideMetforminType 2 diabetesClinical effect

张叙填、方竞国

展开 >

普宁华侨医院内分泌科,广东普宁 515300

格列齐特 二甲双胍 2型糖尿病 临床疗效

2024

糖尿病新世界
中国病理生理学会

糖尿病新世界

影响因子:0.461
ISSN:1672-4062
年,卷(期):2024.27(3)
  • 12